Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: a novel diagnostic tool for therapy stratification of neuroblastoma

Cancer Lett. 2011 Oct 28;309(2):185-9. doi: 10.1016/j.canlet.2011.05.032. Epub 2011 Jun 24.

Abstract

Allelic deletion of the long arm of chromosome 11 (11q loss) is closely associated with the prognosis of neuroblastoma (NB). Here we examined 11q loss using tumor-released DNA fragments in the sera of 24 cases. The allelic intensity score of a panel of polymorphic markers in 11q23 in serum DNA was significantly different between the 11q loss-positive group and the11q loss-negative group. The 11q loss-positive and -negative groups did not overlap when a cut-off value of 0.5 was chosen for the allelic intensity score. Our serum-based 11q loss analysis could predict the allelic status of 11q in tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Base Sequence
  • Child, Preschool
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 11 / genetics*
  • DNA / blood*
  • DNA Fragmentation
  • Humans
  • Infant
  • Microsatellite Repeats / genetics
  • Neuroblastoma / diagnosis*
  • Neuroblastoma / genetics
  • Neuroblastoma / therapy
  • Prognosis
  • Sequence Deletion*

Substances

  • DNA